版本:
中国

BRIEF-Heron Therapeutics says CEO Barry Quart named principal financial officer - SEC filing

April 3 Heron Therapeutics Inc:

* In connection with Brian Drazba's departure, CEO Barry Quart assumed role of principal financial officer, effective April 1, 2017 Source text - bit.ly/2n4wPjS Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐